bf/AMEX:LCTX_icon.png

COM:LINEAGECELL

Lineage Cell Therapeutics, Inc.

  • Stock

Last Close

0.64

21/11 21:00

Market Cap

180.52M

Beta: -

Volume Today

3.71M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
2.86M
-
1.95M
31.97%
2.53M
30.19%
2.25M
11.13%
1.79M
20.43%
1.42M
20.98%
1.48M
4.38%
773K
47.70%
3.90M
404.01%
14.70M
277.39%
8.95M
39.16%
cost of revenue
792.66K
-
837.05K
5.60%
1.11M
32.25%
358K
67.66%
168K
53.07%
302K
79.76%
412K
36.42%
385K
6.55%
1.43M
270.39%
728K
48.95%
1.36M
87.23%
gross profit
2.07M
-
1.11M
46.37%
1.43M
28.64%
1.89M
32.73%
1.62M
14.26%
1.11M
31.40%
1.07M
4.31%
388K
63.60%
2.47M
536.60%
13.97M
465.79%
7.58M
45.75%
selling and marketing expenses
-562.00K
-
general and administrative expenses
15.56M
-
17.56M
12.84%
29.13M
65.95%
28.43M
2.43%
19.92M
29.92%
24.73M
24.11%
24.03M
2.81%
15.57M
35.20%
18.21M
16.96%
22.51M
23.59%
17.30M
23.13%
selling general and administrative expenses
15.56M
-
17.56M
12.84%
29.13M
65.95%
28.43M
2.43%
19.92M
29.92%
24.73M
24.11%
24.03M
2.81%
15.57M
35.20%
18.21M
16.96%
22.51M
23.59%
16.74M
25.63%
research and development expenses
26.61M
-
37.53M
41.05%
42.60M
13.51%
36.11M
15.25%
24.02M
33.46%
20.95M
12.77%
17.95M
14.35%
12.32M
31.37%
33.91M
175.34%
13.99M
58.76%
15.57M
11.35%
other expenses
-209.18K
-
-374.71K
79.14%
-160K
57.30%
-403K
151.88%
1.45M
459.55%
-1.31M
190.75%
-2.04M
54.90%
-1.05M
48.31%
-445K
57.74%
-2.15M
383.60%
-4K
99.81%
cost and expenses
41.39M
-
52.63M
27.16%
68.34M
29.86%
61.22M
10.42%
42.45M
30.66%
42.41M
0.09%
40.35M
4.85%
27.22M
32.55%
53.11M
95.10%
37.22M
29.91%
33.68M
9.52%
operating expenses
40.59M
-
51.79M
27.58%
67.24M
29.82%
60.86M
9.48%
42.28M
30.53%
42.11M
0.40%
39.94M
5.15%
26.84M
32.82%
51.68M
92.59%
36.49M
29.38%
32.31M
11.45%
interest expense
26.09M
-
-6.89M
126.39%
-18.00M
161.33%
-77.59M
331.14%
-17.37M
77.62%
10.87M
162.60%
1.69M
84.50%
5.18M
-
ebitda
-17.12M
-
-50.67M
195.99%
-63.17M
24.66%
-142.38M
125.39%
-53.97M
62.09%
-32.19M
40.35%
-54.30M
68.68%
-25.01M
53.94%
-52.79M
111.06%
-19.82M
62.45%
-24.04M
21.27%
operating income
-55.99M
-
-50.68M
9.47%
-65.81M
29.85%
-58.97M
10.40%
-38.90M
34.03%
-41.80M
7.44%
-38.88M
6.98%
-26.45M
31.97%
-49.21M
86.07%
-22.52M
54.24%
-24.73M
9.83%
depreciation and amortization
3.95M
-
8.41M
112.79%
6.33M
24.69%
4.76M
24.90%
3.30M
30.71%
3.27M
0.70%
-15.43M
571.28%
1.44M
109.30%
-3.58M
349.48%
2.70M
175.31%
692K
74.33%
total other income expenses net
-17.66M
-
-383.64K
97.83%
3.50M
1,012.05%
78.33M
2,138.78%
18.06M
76.95%
-6.85M
137.91%
19.64M
386.91%
4.52M
76.97%
5.94M
31.35%
-3.29M
155.41%
1.45M
144.08%
income before tax
-56.19M
-
-51.15M
8.96%
-62.65M
22.47%
18.62M
129.72%
-23.29M
225.07%
-47.13M
102.37%
-19.23M
59.19%
-21.92M
13.99%
-43.27M
97.36%
-25.81M
40.35%
-23.28M
9.80%
income tax expense
-3.28M
-
-7.38M
124.82%
-4.52M
38.77%
-175.95M
3,796.10%
-37.29M
78.81%
-346K
99.07%
-7.41M
2,040.75%
-1.24M
83.27%
-4.71M
279.82%
541K
111.50%
-1.80M
433.27%
net income
-43.88M
-
-36.41M
17.03%
-46.99M
29.05%
33.57M
171.44%
-19.98M
159.50%
-45.99M
130.23%
-11.83M
74.28%
-20.68M
74.90%
-38.56M
86.43%
-26.35M
31.66%
-21.49M
18.47%
weighted average shs out
54.23M
-
66.47M
22.57%
79.71M
19.93%
97.32M
22.09%
114.48M
17.63%
126.90M
10.86%
145.53M
14.68%
150.04M
3.10%
164.50M
9.64%
169.79M
3.22%
172.66M
1.69%
weighted average shs out dil
54.23M
-
66.47M
22.57%
79.71M
19.93%
99.55M
24.89%
114.48M
14.99%
126.90M
10.86%
145.53M
14.68%
150.04M
3.10%
164.50M
9.64%
169.79M
3.22%
172.66M
1.69%
eps
-0.81
-
-0.55
32.10%
-0.59
7.27%
0.35
159.32%
-0.17
148.57%
-0.36
111.76%
-0.08
77.42%
-0.14
72.20%
-0.23
64.29%
-0.16
30.43%
-0.12
25.00%
epsdiluted
-0.81
-
-0.55
32.10%
-0.59
7.27%
0.34
157.63%
-0.17
150%
-0.36
111.76%
-0.08
77.42%
-0.14
72.20%
-0.23
64.29%
-0.16
30.43%
-0.12
25.00%

All numbers in (except ratios and percentages)